Humanized Mice as a Valuable Pre-Clinical Model for Cancer Immunotherapy Research
Immunotherapy with checkpoint inhibitors opened new horizons in cancer treatment. Clinical trials for novel immunotherapies or unexplored combination regimens either need years of development or are simply impossible to perform like is the case in cancer patients with limited life expectancy. Thus,...
Enregistré dans:
Auteurs principaux: | Morgane M. Cogels, Redouane Rouas, Ghanem E. Ghanem, Philippe Martinive, Ahmad Awada, Dirk Van Gestel, Mohammad Krayem |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Frontiers Media S.A.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f8a3350124704c5bae4f1813a914b018 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
PERSPECTIVES OF FACTORIAL ANALYSIS IN STUDYING ASSOCIATIONS BETWEEN IMMUNE SYSTEM PARAMETERS AND CLINICAL CHARACTERISTICS IN GASTRIC CANCER
par: I. G. Solovyeva, et autres
Publié: (2014) -
Tyrosine-Dependent Phenotype Switching Occurs Early in Many Primary Melanoma Cultures Limiting Their Translational Value
par: Ahmad Najem, et autres
Publié: (2021) - Journal for immunotherapy of cancer
-
Cancer Vaccines and Immunotherapy for Tumor Prevention and Treatment
par: Jagmohan Singh, et autres
Publié: (2021) -
Immunotherapy for Stage III NSCLC: Durvalumab and Beyond
par: Fitzpatrick O, et autres
Publié: (2021)